

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.95880976 |
| 2 | somite rostral/caudal axis specification (GO:0032525) | 6.70940693 |
| 3 | regulation of response to osmotic stress (GO:0047484) | 6.70160098 |
| 4 | maintenance of protein location in nucleus (GO:0051457) | 6.60021263 |
| 5 | protein localization to kinetochore (GO:0034501) | 6.55504289 |
| 6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.28296824 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.04314800 |
| 8 | negative regulation of epidermis development (GO:0045683) | 5.73486970 |
| 9 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.73268322 |
| 10 | adaptation of signaling pathway (GO:0023058) | 5.68074888 |
| 11 | muscle organ morphogenesis (GO:0048644) | 5.65234739 |
| 12 | rRNA transcription (GO:0009303) | 5.56523993 |
| 13 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.51593921 |
| 14 | histone H4-K8 acetylation (GO:0043982) | 5.45238064 |
| 15 | histone H4-K5 acetylation (GO:0043981) | 5.45238064 |
| 16 | histone H4-K12 acetylation (GO:0043983) | 5.45205909 |
| 17 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.39496203 |
| 18 | negative regulation of telomerase activity (GO:0051974) | 5.25411441 |
| 19 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.17885068 |
| 20 | hormone catabolic process (GO:0042447) | 4.99948485 |
| 21 | cochlea development (GO:0090102) | 4.97503344 |
| 22 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.94631668 |
| 23 | response to histamine (GO:0034776) | 4.91745865 |
| 24 | regulation of cilium movement (GO:0003352) | 4.86556131 |
| 25 | heterochromatin organization (GO:0070828) | 4.86490996 |
| 26 | cytidine deamination (GO:0009972) | 4.80812620 |
| 27 | cytidine metabolic process (GO:0046087) | 4.80812620 |
| 28 | cytidine catabolic process (GO:0006216) | 4.80812620 |
| 29 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.75317782 |
| 30 | protein localization to chromosome, centromeric region (GO:0071459) | 4.74999578 |
| 31 | inner ear receptor cell development (GO:0060119) | 4.72030923 |
| 32 | mitotic sister chromatid segregation (GO:0000070) | 4.68506735 |
| 33 | flavonoid metabolic process (GO:0009812) | 4.62731789 |
| 34 | interferon-gamma production (GO:0032609) | 4.61793359 |
| 35 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.58822305 |
| 36 | phenol-containing compound catabolic process (GO:0019336) | 4.47250919 |
| 37 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.45436343 |
| 38 | detection of light stimulus involved in visual perception (GO:0050908) | 4.45436343 |
| 39 | NAD biosynthetic process (GO:0009435) | 4.41512526 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.39667674 |
| 41 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.38040592 |
| 42 | notochord development (GO:0030903) | 4.33790781 |
| 43 | chromatin assembly (GO:0031497) | 4.30728356 |
| 44 | rRNA methylation (GO:0031167) | 4.26368258 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 4.25842466 |
| 46 | positive regulation of protein deacetylation (GO:0090312) | 4.24938162 |
| 47 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 4.24721935 |
| 48 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.24604624 |
| 49 | behavioral response to nicotine (GO:0035095) | 4.20036724 |
| 50 | histone H4-K16 acetylation (GO:0043984) | 4.15847771 |
| 51 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.14298266 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.14125925 |
| 53 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.11250706 |
| 54 | response to dietary excess (GO:0002021) | 4.09188737 |
| 55 | nuclear pore complex assembly (GO:0051292) | 4.08579694 |
| 56 | primitive streak formation (GO:0090009) | 4.06925666 |
| 57 | regulation of germinal center formation (GO:0002634) | 4.04916881 |
| 58 | nucleoside transmembrane transport (GO:1901642) | 4.01584054 |
| 59 | sister chromatid segregation (GO:0000819) | 3.99301668 |
| 60 | protein K11-linked deubiquitination (GO:0035871) | 3.98112072 |
| 61 | regulation of translation in response to stress (GO:0043555) | 3.89139425 |
| 62 | vagina development (GO:0060068) | 3.84924332 |
| 63 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.84700449 |
| 64 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.84700449 |
| 65 | rRNA modification (GO:0000154) | 3.83133118 |
| 66 | transepithelial transport (GO:0070633) | 3.82531470 |
| 67 | auditory receptor cell stereocilium organization (GO:0060088) | 3.81455828 |
| 68 | microtubule severing (GO:0051013) | 3.80482939 |
| 69 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.78354576 |
| 70 | negative regulation of telomere maintenance (GO:0032205) | 3.75733212 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.75552687 |
| 72 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.71649488 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 3.70150982 |
| 74 | female genitalia development (GO:0030540) | 3.68988244 |
| 75 | response to pheromone (GO:0019236) | 3.68577227 |
| 76 | icosanoid secretion (GO:0032309) | 3.67851248 |
| 77 | arachidonic acid secretion (GO:0050482) | 3.67851248 |
| 78 | DNA replication checkpoint (GO:0000076) | 3.66243907 |
| 79 | quinone metabolic process (GO:1901661) | 3.66165836 |
| 80 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.65145231 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 3.64950123 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 3.64950123 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.64950123 |
| 84 | maintenance of protein localization in organelle (GO:0072595) | 3.63775406 |
| 85 | mitochondrion distribution (GO:0048311) | 3.60922053 |
| 86 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.60865621 |
| 87 | protein polyglutamylation (GO:0018095) | 3.59667152 |
| 88 | RNA stabilization (GO:0043489) | 3.55533636 |
| 89 | mRNA stabilization (GO:0048255) | 3.55533636 |
| 90 | vitamin A metabolic process (GO:0006776) | 3.52300254 |
| 91 | retinoic acid receptor signaling pathway (GO:0048384) | 3.48115750 |
| 92 | nuclear pore organization (GO:0006999) | 3.46615148 |
| 93 | bone trabecula formation (GO:0060346) | 3.45842666 |
| 94 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.44985051 |
| 95 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.43119328 |
| 96 | cornea development in camera-type eye (GO:0061303) | 3.41977386 |
| 97 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.41790654 |
| 98 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.40754793 |
| 99 | pre-miRNA processing (GO:0031054) | 3.37273445 |
| 100 | maternal placenta development (GO:0001893) | 3.36030189 |
| 101 | positive regulation of muscle cell apoptotic process (GO:0010661) | 3.35851566 |
| 102 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.34951940 |
| 103 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.34942116 |
| 104 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.34942116 |
| 105 | cardiovascular system development (GO:0072358) | 3.32990432 |
| 106 | ventricular system development (GO:0021591) | 3.32871869 |
| 107 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.31989064 |
| 108 | tryptophan metabolic process (GO:0006568) | 3.29818541 |
| 109 | fucose catabolic process (GO:0019317) | 3.28519857 |
| 110 | L-fucose metabolic process (GO:0042354) | 3.28519857 |
| 111 | L-fucose catabolic process (GO:0042355) | 3.28519857 |
| 112 | neural tube formation (GO:0001841) | 3.28296575 |
| 113 | reflex (GO:0060004) | 3.26154850 |
| 114 | regulation of telomere maintenance (GO:0032204) | 3.25890895 |
| 115 | intestinal epithelial cell development (GO:0060576) | 3.25667269 |
| 116 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.25189675 |
| 117 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.25189675 |
| 118 | negative regulation of interleukin-2 production (GO:0032703) | 3.24704169 |
| 119 | epoxygenase P450 pathway (GO:0019373) | 3.24454121 |
| 120 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.22718171 |
| 121 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.21205168 |
| 122 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.20612452 |
| 123 | apoptotic DNA fragmentation (GO:0006309) | 3.17647562 |
| 124 | cell differentiation involved in metanephros development (GO:0072202) | 3.17485899 |
| 125 | adrenergic receptor signaling pathway (GO:0071875) | 3.16648255 |
| 126 | inner ear receptor stereocilium organization (GO:0060122) | 3.14272491 |
| 127 | establishment of endothelial barrier (GO:0061028) | 3.13960703 |
| 128 | cellular response to ammonium ion (GO:0071242) | 3.13792157 |
| 129 | trophectodermal cell differentiation (GO:0001829) | 3.13754557 |
| 130 | kynurenine metabolic process (GO:0070189) | 3.12399532 |
| 131 | regulation of telomerase activity (GO:0051972) | 3.11391229 |
| 132 | proline transport (GO:0015824) | 3.10156869 |
| 133 | snRNA processing (GO:0016180) | 3.08788295 |
| 134 | pore complex assembly (GO:0046931) | 3.08631720 |
| 135 | establishment of protein localization to Golgi (GO:0072600) | 3.08143921 |
| 136 | photoreceptor cell maintenance (GO:0045494) | 3.07500513 |
| 137 | innervation (GO:0060384) | 3.06093582 |
| 138 | cofactor transport (GO:0051181) | 3.05393488 |
| 139 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.05264636 |
| 140 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.05210251 |
| 141 | righting reflex (GO:0060013) | 3.04760794 |
| 142 | rhodopsin mediated signaling pathway (GO:0016056) | 3.03390638 |
| 143 | DNA duplex unwinding (GO:0032508) | 3.03038207 |
| 144 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.00935489 |
| 145 | * tachykinin receptor signaling pathway (GO:0007217) | 2.98084068 |
| 146 | DNA geometric change (GO:0032392) | 2.97623104 |
| 147 | brain morphogenesis (GO:0048854) | 2.97383973 |
| 148 | regulation of hippo signaling (GO:0035330) | 2.96779476 |
| 149 | regulation of timing of cell differentiation (GO:0048505) | 2.95384341 |
| 150 | piRNA metabolic process (GO:0034587) | 2.94023536 |
| 151 | indole-containing compound metabolic process (GO:0042430) | 2.93058708 |
| 152 | negative regulation of astrocyte differentiation (GO:0048712) | 2.91365904 |
| 153 | L-methionine salvage (GO:0071267) | 2.90828200 |
| 154 | L-methionine biosynthetic process (GO:0071265) | 2.90828200 |
| 155 | amino acid salvage (GO:0043102) | 2.90828200 |
| 156 | negative regulation of multicellular organism growth (GO:0040015) | 2.89674371 |
| 157 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.81500481 |
| 158 | embryonic epithelial tube formation (GO:0001838) | 2.78238176 |
| 159 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.72855149 |
| 160 | cAMP catabolic process (GO:0006198) | 2.72319488 |
| 161 | axoneme assembly (GO:0035082) | 2.69831800 |
| 162 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.68632681 |
| 163 | primary amino compound metabolic process (GO:1901160) | 2.64185029 |
| 164 | serotonin metabolic process (GO:0042428) | 2.63498648 |
| 165 | negative regulation of mast cell activation (GO:0033004) | 2.62221942 |
| 166 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.60431193 |
| 167 | gamma-aminobutyric acid transport (GO:0015812) | 2.59265535 |
| 168 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.58952109 |
| 169 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.58571304 |
| 170 | central nervous system neuron axonogenesis (GO:0021955) | 2.57339494 |
| 171 | nephron tubule formation (GO:0072079) | 2.56159109 |
| 172 | cellular response to exogenous dsRNA (GO:0071360) | 2.55120934 |
| 173 | epithelial tube formation (GO:0072175) | 2.54078638 |
| 174 | regulation of meiosis I (GO:0060631) | 2.53573925 |
| 175 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.53563499 |
| 176 | ADP metabolic process (GO:0046031) | 2.53280174 |
| 177 | regulation of development, heterochronic (GO:0040034) | 2.52535259 |
| 178 | ncRNA 3-end processing (GO:0043628) | 2.51680133 |
| 179 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.51368880 |
| 180 | behavioral response to ethanol (GO:0048149) | 2.49690709 |
| 181 | positive regulation of mast cell degranulation (GO:0043306) | 2.49014875 |
| 182 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.49014875 |
| 183 | visual perception (GO:0007601) | 2.47553858 |
| 184 | regulation of guanylate cyclase activity (GO:0031282) | 2.47547110 |
| 185 | sensory perception of light stimulus (GO:0050953) | 2.46791384 |
| 186 | negative regulation of metanephros development (GO:0072217) | 2.46567573 |
| 187 | rRNA catabolic process (GO:0016075) | 2.46149213 |
| 188 | sulfation (GO:0051923) | 2.44404737 |
| 189 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.44048021 |
| 190 | snRNA metabolic process (GO:0016073) | 2.43751838 |
| 191 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.43378433 |
| 192 | cyclic nucleotide catabolic process (GO:0009214) | 2.42289914 |
| 193 | DNA integration (GO:0015074) | 2.41942465 |
| 194 | multicellular organism reproduction (GO:0032504) | 2.41758523 |
| 195 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.39407449 |
| 196 | daunorubicin metabolic process (GO:0044597) | 10.8451949 |
| 197 | polyketide metabolic process (GO:0030638) | 10.8451949 |
| 198 | doxorubicin metabolic process (GO:0044598) | 10.8451949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.70001093 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.08547271 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.08547271 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.08547271 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68376840 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.51208433 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.79673308 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.53245116 |
| 9 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.16054710 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.10727862 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.00458233 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.91381879 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.87282433 |
| 14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.85007502 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.68110570 |
| 16 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.66408315 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.58160798 |
| 18 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.56111095 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.47759005 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.38745685 |
| 21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.36349333 |
| 22 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.30406425 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24833253 |
| 24 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.18981403 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.15744181 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.10122349 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.07934194 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05840352 |
| 29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05088453 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04868509 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.01917579 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 2.01897198 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.00152088 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99042785 |
| 35 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97729959 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96791867 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.93866592 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93224550 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.91625365 |
| 40 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.91349974 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.89929065 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86749848 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86146665 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.84619217 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81911360 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80479979 |
| 47 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.78985160 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.78132504 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74865586 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.73533990 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.73491028 |
| 52 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.72205772 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.68927193 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.68927193 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68575669 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.68361265 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65804131 |
| 58 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.65804131 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.65739751 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65103462 |
| 61 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.61490302 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61289473 |
| 63 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.61135410 |
| 64 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58599278 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57981103 |
| 66 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.57246007 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.55063311 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.52853389 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52329207 |
| 70 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.50914745 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50813601 |
| 72 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.48052981 |
| 73 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.46063525 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45368508 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44218753 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42586633 |
| 77 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40997838 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.39513020 |
| 79 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.39237019 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37992242 |
| 81 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.36687400 |
| 82 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35441956 |
| 83 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.34704039 |
| 84 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.33583622 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.33330413 |
| 86 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.32931681 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31738861 |
| 88 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31715689 |
| 89 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.29714022 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29455820 |
| 91 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29236141 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29105894 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29105894 |
| 94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27671005 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27608123 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27402540 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27348501 |
| 98 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26611551 |
| 99 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.26558866 |
| 100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26125728 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25769228 |
| 102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25533644 |
| 103 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24675226 |
| 104 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24096613 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24059056 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23858813 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22399987 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21755892 |
| 109 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21242346 |
| 110 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21002920 |
| 111 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20950174 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20225480 |
| 113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.19818780 |
| 114 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19625889 |
| 115 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.19459705 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19092868 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19012327 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18132505 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18126353 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17794011 |
| 121 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17212768 |
| 122 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16384048 |
| 123 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15877602 |
| 124 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15794547 |
| 125 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14723420 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14320853 |
| 127 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14221439 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14058244 |
| 129 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13147407 |
| 130 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12647819 |
| 131 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12630186 |
| 132 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12478227 |
| 133 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.11905287 |
| 134 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11484041 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11394552 |
| 136 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10893691 |
| 137 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10822853 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10333752 |
| 139 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09249379 |
| 140 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.06539825 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05901076 |
| 142 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05738630 |
| 143 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04702054 |
| 144 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04555092 |
| 145 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04424081 |
| 146 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03971598 |
| 147 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03610925 |
| 148 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03594478 |
| 149 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03496139 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03421965 |
| 151 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03288141 |
| 152 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02577481 |
| 153 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.01084934 |
| 154 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.01084934 |
| 155 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00023117 |
| 156 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99821239 |
| 157 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.99247973 |
| 158 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98997284 |
| 159 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98902069 |
| 160 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98785175 |
| 161 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98113759 |
| 162 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97955194 |
| 163 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96687707 |
| 164 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96083117 |
| 165 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.95014270 |
| 166 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94864715 |
| 167 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94529223 |
| 168 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93765578 |
| 169 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93510235 |
| 170 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93471483 |
| 171 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.91333747 |
| 172 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.90453735 |
| 173 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.90116927 |
| 174 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89406960 |
| 175 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88640585 |
| 176 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.88612631 |
| 177 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.88067937 |
| 178 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86827056 |
| 179 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84706712 |
| 180 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84014699 |
| 181 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83374037 |
| 182 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82777970 |
| 183 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81674304 |
| 184 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80770904 |
| 185 | P68_20966046_ChIP-Seq_HELA_Human | 0.80137888 |
| 186 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.79157876 |
| 187 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.76677214 |
| 188 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.76329772 |
| 189 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.76040832 |
| 190 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.74565483 |
| 191 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.74501273 |
| 192 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.74304152 |
| 193 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.74155297 |
| 194 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.74149340 |
| 195 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.73705034 |
| 196 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.72640431 |
| 197 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70873087 |
| 198 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70035968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 4.98995535 |
| 2 | MP0002254_reproductive_system_inflammat | 4.87454871 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.42974374 |
| 4 | MP0003011_delayed_dark_adaptation | 4.33377369 |
| 5 | MP0005394_taste/olfaction_phenotype | 4.14509629 |
| 6 | MP0005499_abnormal_olfactory_system | 4.14509629 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.87412360 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.56237648 |
| 9 | MP0001501_abnormal_sleep_pattern | 3.49769037 |
| 10 | MP0000372_irregular_coat_pigmentation | 3.33772702 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 3.14258768 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 3.13702217 |
| 13 | MP0008057_abnormal_DNA_replication | 3.06972191 |
| 14 | MP0003646_muscle_fatigue | 3.06850956 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.91794650 |
| 16 | MP0004858_abnormal_nervous_system | 2.82235166 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.81119011 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.63207500 |
| 19 | MP0003122_maternal_imprinting | 2.55898623 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.42107520 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.35879770 |
| 22 | MP0008872_abnormal_physiological_respon | 2.34376762 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.28507697 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.27846955 |
| 25 | MP0008877_abnormal_DNA_methylation | 2.14553152 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 2.13802762 |
| 27 | MP0005257_abnormal_intraocular_pressure | 2.10910860 |
| 28 | MP0003121_genomic_imprinting | 2.10861648 |
| 29 | MP0002735_abnormal_chemical_nociception | 2.08101448 |
| 30 | MP0002736_abnormal_nociception_after | 1.99499878 |
| 31 | MP0002653_abnormal_ependyma_morphology | 1.99257019 |
| 32 | MP0008789_abnormal_olfactory_epithelium | 1.99251854 |
| 33 | MP0006082_CNS_inflammation | 1.95739873 |
| 34 | MP0005253_abnormal_eye_physiology | 1.94133565 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.92359900 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.89384340 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.82614718 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.82349328 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.78759871 |
| 40 | MP0009745_abnormal_behavioral_response | 1.78713951 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.76673656 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.75158473 |
| 43 | MP0001672_abnormal_embryogenesis/_devel | 1.71676160 |
| 44 | MP0005380_embryogenesis_phenotype | 1.71676160 |
| 45 | MP0005671_abnormal_response_to | 1.68366029 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.67649073 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.66120140 |
| 48 | MP0003984_embryonic_growth_retardation | 1.63892606 |
| 49 | MP0002102_abnormal_ear_morphology | 1.62446768 |
| 50 | MP0003938_abnormal_ear_development | 1.62326913 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.61971260 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.59874202 |
| 53 | MP0009046_muscle_twitch | 1.52783020 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.52683538 |
| 55 | MP0003136_yellow_coat_color | 1.51084857 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.49745074 |
| 57 | MP0001849_ear_inflammation | 1.49546084 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.48144825 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.44410037 |
| 60 | MP0001970_abnormal_pain_threshold | 1.42427649 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.42079996 |
| 62 | MP0002233_abnormal_nose_morphology | 1.41057904 |
| 63 | MP0002932_abnormal_joint_morphology | 1.41018566 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 1.40507790 |
| 65 | MP0001486_abnormal_startle_reflex | 1.40312815 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 1.38362994 |
| 67 | MP0003878_abnormal_ear_physiology | 1.38362994 |
| 68 | MP0005647_abnormal_sex_gland | 1.36304785 |
| 69 | MP0000350_abnormal_cell_proliferation | 1.35978816 |
| 70 | MP0002092_abnormal_eye_morphology | 1.34327111 |
| 71 | MP0002928_abnormal_bile_duct | 1.32947673 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.32806807 |
| 73 | MP0004043_abnormal_pH_regulation | 1.32281561 |
| 74 | MP0001293_anophthalmia | 1.31077977 |
| 75 | MP0000015_abnormal_ear_pigmentation | 1.27909242 |
| 76 | MP0005266_abnormal_metabolism | 1.25747812 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 1.24625178 |
| 78 | MP0000762_abnormal_tongue_morphology | 1.24609551 |
| 79 | MP0002970_abnormal_white_adipose | 1.23307553 |
| 80 | MP0001984_abnormal_olfaction | 1.23272599 |
| 81 | MP0003123_paternal_imprinting | 1.22883000 |
| 82 | MP0003635_abnormal_synaptic_transmissio | 1.22559507 |
| 83 | MP0000427_abnormal_hair_cycle | 1.22189903 |
| 84 | MP0002086_abnormal_extraembryonic_tissu | 1.16938031 |
| 85 | MP0004484_altered_response_of | 1.16669148 |
| 86 | MP0002184_abnormal_innervation | 1.15681217 |
| 87 | MP0004142_abnormal_muscle_tone | 1.14253561 |
| 88 | MP0001835_abnormal_antigen_presentation | 1.13709058 |
| 89 | MP0002085_abnormal_embryonic_tissue | 1.12262249 |
| 90 | MP0002067_abnormal_sensory_capabilities | 1.11919127 |
| 91 | MP0003077_abnormal_cell_cycle | 1.11398979 |
| 92 | MP0000026_abnormal_inner_ear | 1.10498371 |
| 93 | MP0004147_increased_porphyrin_level | 1.09847006 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 1.09656255 |
| 95 | MP0002272_abnormal_nervous_system | 1.08856620 |
| 96 | MP0001963_abnormal_hearing_physiology | 1.08835841 |
| 97 | MP0003718_maternal_effect | 1.06938283 |
| 98 | MP0003880_abnormal_central_pattern | 1.06331609 |
| 99 | MP0000750_abnormal_muscle_regeneration | 1.06209009 |
| 100 | MP0002114_abnormal_axial_skeleton | 1.05033582 |
| 101 | MP0004885_abnormal_endolymph | 1.04818856 |
| 102 | MP0002876_abnormal_thyroid_physiology | 1.04358008 |
| 103 | MP0002168_other_aberrant_phenotype | 1.02009262 |
| 104 | MP0000049_abnormal_middle_ear | 0.99903764 |
| 105 | MP0000631_abnormal_neuroendocrine_gland | 0.99669704 |
| 106 | MP0002229_neurodegeneration | 0.99277765 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 0.99222519 |
| 108 | MP0002163_abnormal_gland_morphology | 0.98976893 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.98581263 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.98556192 |
| 111 | MP0001800_abnormal_humoral_immune | 0.96890252 |
| 112 | MP0004197_abnormal_fetal_growth/weight/ | 0.95585361 |
| 113 | MP0000371_diluted_coat_color | 0.95544148 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.94777611 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.94684705 |
| 116 | MP0008770_decreased_survivor_rate | 0.94462330 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.94073724 |
| 118 | MP0003935_abnormal_craniofacial_develop | 0.93789281 |
| 119 | MP0002084_abnormal_developmental_patter | 0.93443628 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.92761989 |
| 121 | MP0000432_abnormal_head_morphology | 0.92584715 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 0.91952273 |
| 123 | MP0004742_abnormal_vestibular_system | 0.91894916 |
| 124 | MP0004381_abnormal_hair_follicle | 0.90481660 |
| 125 | MP0000749_muscle_degeneration | 0.90162203 |
| 126 | MP0002132_abnormal_respiratory_system | 0.89352581 |
| 127 | MP0002095_abnormal_skin_pigmentation | 0.89030939 |
| 128 | MP0005171_absent_coat_pigmentation | 0.88155089 |
| 129 | MP0002752_abnormal_somatic_nervous | 0.87881683 |
| 130 | MP0001764_abnormal_homeostasis | 0.86866048 |
| 131 | MP0003787_abnormal_imprinting | 0.86672913 |
| 132 | MP0009703_decreased_birth_body | 0.86655917 |
| 133 | MP0000428_abnormal_craniofacial_morphol | 0.86591180 |
| 134 | MP0003137_abnormal_impulse_conducting | 0.86038347 |
| 135 | MP0002063_abnormal_learning/memory/cond | 0.85891669 |
| 136 | MP0002064_seizures | 0.84820473 |
| 137 | MP0000778_abnormal_nervous_system | 0.84633899 |
| 138 | MP0005395_other_phenotype | 0.83303786 |
| 139 | MP0000490_abnormal_crypts_of | 0.83049965 |
| 140 | MP0003950_abnormal_plasma_membrane | 0.82962003 |
| 141 | MP0002734_abnormal_mechanical_nocicepti | 0.82875006 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.82538844 |
| 143 | MP0000313_abnormal_cell_death | 0.82343652 |
| 144 | MP0003698_abnormal_male_reproductive | 0.80920149 |
| 145 | MP0003045_fibrosis | 0.80836804 |
| 146 | MP0005195_abnormal_posterior_eye | 0.80428881 |
| 147 | MP0002090_abnormal_vision | 0.80391007 |
| 148 | MP0000383_abnormal_hair_follicle | 0.79100310 |
| 149 | MP0004883_abnormal_blood_vessel | 0.78823549 |
| 150 | MP0004145_abnormal_muscle_electrophysio | 0.78494448 |
| 151 | MP0002693_abnormal_pancreas_physiology | 0.77962039 |
| 152 | MP0003755_abnormal_palate_morphology | 0.77579952 |
| 153 | MP0003763_abnormal_thymus_physiology | 0.77360271 |
| 154 | MP0002925_abnormal_cardiovascular_devel | 0.77322871 |
| 155 | MP0005084_abnormal_gallbladder_morpholo | 0.76684596 |
| 156 | MP0003786_premature_aging | 0.75375246 |
| 157 | MP0003111_abnormal_nucleus_morphology | 0.74005490 |
| 158 | MP0001730_embryonic_growth_arrest | 0.73891949 |
| 159 | MP0005410_abnormal_fertilization | 0.73398118 |
| 160 | MP0009780_abnormal_chondrocyte_physiolo | 0.72603573 |
| 161 | MP0002751_abnormal_autonomic_nervous | 0.72065467 |
| 162 | MP0005023_abnormal_wound_healing | 0.71962843 |
| 163 | MP0001119_abnormal_female_reproductive | 0.71929435 |
| 164 | MP0005508_abnormal_skeleton_morphology | 0.71289958 |
| 165 | MP0002098_abnormal_vibrissa_morphology | 0.71289159 |
| 166 | MP0002080_prenatal_lethality | 0.70561220 |
| 167 | MP0005391_vision/eye_phenotype | 0.70429139 |
| 168 | MP0002938_white_spotting | 0.70370867 |
| 169 | MP0004924_abnormal_behavior | 0.69975035 |
| 170 | MP0005386_behavior/neurological_phenoty | 0.69975035 |
| 171 | MP0005248_abnormal_Harderian_gland | 0.67579205 |
| 172 | MP0002269_muscular_atrophy | 0.66775482 |
| 173 | MP0000377_abnormal_hair_follicle | 0.66580175 |
| 174 | MP0010678_abnormal_skin_adnexa | 0.65934520 |
| 175 | MP0001697_abnormal_embryo_size | 0.65795231 |
| 176 | MP0003119_abnormal_digestive_system | 0.64795784 |
| 177 | MP0010094_abnormal_chromosome_stability | 0.63921936 |
| 178 | MP0002796_impaired_skin_barrier | 0.60992109 |
| 179 | MP0009115_abnormal_fat_cell | 0.59772635 |
| 180 | MP0002019_abnormal_tumor_incidence | 0.58911173 |
| 181 | MP0002116_abnormal_craniofacial_bone | 0.58448374 |
| 182 | MP0005310_abnormal_salivary_gland | 0.58018969 |
| 183 | MP0004133_heterotaxia | 0.57016414 |
| 184 | MP0002722_abnormal_immune_system | 0.55852875 |
| 185 | MP0002405_respiratory_system_inflammati | 0.55423844 |
| 186 | MP0001727_abnormal_embryo_implantation | 0.53402558 |
| 187 | MP0000689_abnormal_spleen_morphology | 0.52713213 |
| 188 | MP0005197_abnormal_uvea_morphology | 0.51701873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.31488782 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.24997766 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 6.03433838 |
| 4 | Decreased central vision (HP:0007663) | 5.34788687 |
| 5 | Multiple enchondromatosis (HP:0005701) | 5.22283150 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 5.11741757 |
| 7 | Hepatoblastoma (HP:0002884) | 5.09970027 |
| 8 | Rib fusion (HP:0000902) | 5.02679528 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 4.57987373 |
| 10 | Ependymoma (HP:0002888) | 4.38161998 |
| 11 | Neoplasm of striated muscle (HP:0009728) | 4.24766728 |
| 12 | Pancreatic cysts (HP:0001737) | 4.13656807 |
| 13 | Rhabdomyosarcoma (HP:0002859) | 4.06301086 |
| 14 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.94421843 |
| 15 | True hermaphroditism (HP:0010459) | 3.84796180 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.66484132 |
| 17 | Pancreatic fibrosis (HP:0100732) | 3.66320024 |
| 18 | Poikiloderma (HP:0001029) | 3.62796841 |
| 19 | Testicular atrophy (HP:0000029) | 3.44770258 |
| 20 | Macular degeneration (HP:0000608) | 3.38931790 |
| 21 | Partial duplication of thumb phalanx (HP:0009944) | 3.36809833 |
| 22 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.32070225 |
| 23 | Horizontal nystagmus (HP:0000666) | 3.30236667 |
| 24 | Pendular nystagmus (HP:0012043) | 3.26955162 |
| 25 | Chronic hepatic failure (HP:0100626) | 3.25529892 |
| 26 | Bifid tongue (HP:0010297) | 3.20771387 |
| 27 | Fused cervical vertebrae (HP:0002949) | 3.19369532 |
| 28 | Constricted visual fields (HP:0001133) | 3.17185697 |
| 29 | Nephronophthisis (HP:0000090) | 3.14511833 |
| 30 | Rectovaginal fistula (HP:0000143) | 3.14484918 |
| 31 | Rectal fistula (HP:0100590) | 3.14484918 |
| 32 | Astrocytoma (HP:0009592) | 3.10686362 |
| 33 | Abnormality of the astrocytes (HP:0100707) | 3.10686362 |
| 34 | Abnormality of the salivary glands (HP:0010286) | 3.09448324 |
| 35 | Trismus (HP:0000211) | 3.08478023 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.06820550 |
| 37 | Dyschromatopsia (HP:0007641) | 3.06518669 |
| 38 | Embryonal renal neoplasm (HP:0011794) | 3.06424856 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 3.04660433 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 3.03406785 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 3.03406785 |
| 42 | Gaze-evoked nystagmus (HP:0000640) | 3.01181862 |
| 43 | Anomalous pulmonary venous return (HP:0010772) | 3.00548274 |
| 44 | Chorioretinal atrophy (HP:0000533) | 2.98807493 |
| 45 | Vaginal fistula (HP:0004320) | 2.96078722 |
| 46 | Intestinal fistula (HP:0100819) | 2.95965293 |
| 47 | Hypochromic anemia (HP:0001931) | 2.95034000 |
| 48 | Ragged-red muscle fibers (HP:0003200) | 2.92030625 |
| 49 | Amyotrophic lateral sclerosis (HP:0007354) | 2.90997263 |
| 50 | Partial duplication of the phalanx of hand (HP:0009999) | 2.90481644 |
| 51 | IgG deficiency (HP:0004315) | 2.88694098 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.87803638 |
| 53 | Hypoplasia of the fovea (HP:0007750) | 2.83522060 |
| 54 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.83522060 |
| 55 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.80110190 |
| 56 | Preauricular skin tag (HP:0000384) | 2.77336838 |
| 57 | Congenital sensorineural hearing impairment (HP:0008527) | 2.77302311 |
| 58 | Abnormality of the renal medulla (HP:0100957) | 2.77076819 |
| 59 | Abnormality of the renal cortex (HP:0011035) | 2.76496028 |
| 60 | Abnormal cartilage morphology (HP:0002763) | 2.75368299 |
| 61 | Genetic anticipation (HP:0003743) | 2.75214164 |
| 62 | Nasal polyposis (HP:0100582) | 2.73391151 |
| 63 | Medial flaring of the eyebrow (HP:0010747) | 2.73190510 |
| 64 | Progressive inability to walk (HP:0002505) | 2.70796842 |
| 65 | Generalized hypotonia (HP:0001290) | 2.69413507 |
| 66 | Episodic fever (HP:0001954) | 2.67066813 |
| 67 | Genital tract atresia (HP:0001827) | 2.65066058 |
| 68 | Abnormal lung lobation (HP:0002101) | 2.64673520 |
| 69 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.61244192 |
| 70 | Chromsome breakage (HP:0040012) | 2.59066343 |
| 71 | Short humerus (HP:0005792) | 2.57096642 |
| 72 | Abnormality of the pulmonary veins (HP:0011718) | 2.56133832 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.55965972 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.55961965 |
| 75 | Neoplasm of the heart (HP:0100544) | 2.55951702 |
| 76 | Periauricular skin pits (HP:0100277) | 2.53268354 |
| 77 | Preauricular pit (HP:0004467) | 2.53268354 |
| 78 | Focal motor seizures (HP:0011153) | 2.52889589 |
| 79 | Skin tags (HP:0010609) | 2.52749535 |
| 80 | Vaginal atresia (HP:0000148) | 2.50906560 |
| 81 | Type II lissencephaly (HP:0007260) | 2.50824940 |
| 82 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.49444757 |
| 83 | Difficulty running (HP:0009046) | 2.49209116 |
| 84 | Abnormality of chromosome segregation (HP:0002916) | 2.48851251 |
| 85 | Short 5th finger (HP:0009237) | 2.46465065 |
| 86 | Cystic liver disease (HP:0006706) | 2.46035424 |
| 87 | Sensory axonal neuropathy (HP:0003390) | 2.44872740 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44852089 |
| 89 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.44672433 |
| 90 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44628935 |
| 91 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.44474703 |
| 92 | Progressive muscle weakness (HP:0003323) | 2.44453713 |
| 93 | Villous atrophy (HP:0011473) | 2.42262994 |
| 94 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.42262994 |
| 95 | Impulsivity (HP:0100710) | 2.41881130 |
| 96 | Decreased circulating renin level (HP:0003351) | 2.41561069 |
| 97 | Large earlobe (HP:0009748) | 2.38278862 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 2.38232921 |
| 99 | Increased connective tissue (HP:0009025) | 2.36711932 |
| 100 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.35335767 |
| 101 | Gait imbalance (HP:0002141) | 2.34918305 |
| 102 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.33352194 |
| 103 | Reduced antithrombin III activity (HP:0001976) | 2.32283529 |
| 104 | Congenital primary aphakia (HP:0007707) | 2.27428471 |
| 105 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.27138476 |
| 106 | Abnormality of the nasal mucosa (HP:0000433) | 2.22873481 |
| 107 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.22324445 |
| 108 | Focal seizures (HP:0007359) | 2.22124521 |
| 109 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.21967026 |
| 110 | Febrile seizures (HP:0002373) | 2.21338495 |
| 111 | Shawl scrotum (HP:0000049) | 2.21115104 |
| 112 | Keratoconus (HP:0000563) | 2.20324744 |
| 113 | Increased corneal curvature (HP:0100692) | 2.20324744 |
| 114 | Glioma (HP:0009733) | 2.20132381 |
| 115 | Hypopigmentation of the fundus (HP:0007894) | 2.20130823 |
| 116 | Tongue fasciculations (HP:0001308) | 2.20073636 |
| 117 | Anhidrosis (HP:0000970) | 2.20031179 |
| 118 | Renal duplication (HP:0000075) | 2.19332378 |
| 119 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18574382 |
| 120 | Facial shape deformation (HP:0011334) | 2.18096347 |
| 121 | Potter facies (HP:0002009) | 2.18096347 |
| 122 | Hyperventilation (HP:0002883) | 2.16559971 |
| 123 | Nasolacrimal duct obstruction (HP:0000579) | 2.15794709 |
| 124 | Polydipsia (HP:0001959) | 2.14491145 |
| 125 | Abnormal drinking behavior (HP:0030082) | 2.14491145 |
| 126 | Tetraplegia (HP:0002445) | 2.14439600 |
| 127 | Pseudobulbar signs (HP:0002200) | 2.14080514 |
| 128 | Abnormality of the pubic bones (HP:0003172) | 2.13224364 |
| 129 | Cerebellar dysplasia (HP:0007033) | 2.13160367 |
| 130 | Inability to walk (HP:0002540) | 2.11934319 |
| 131 | Cheilitis (HP:0100825) | 2.11096470 |
| 132 | Vertebral fusion (HP:0002948) | 2.09348660 |
| 133 | Microretrognathia (HP:0000308) | 2.08444218 |
| 134 | Skin pits (HP:0100276) | 2.08405389 |
| 135 | Abnormality of the fovea (HP:0000493) | 2.07793612 |
| 136 | Abnormal biliary tract physiology (HP:0012439) | 2.07592037 |
| 137 | Bile duct proliferation (HP:0001408) | 2.07592037 |
| 138 | Congenital hepatic fibrosis (HP:0002612) | 2.06874222 |
| 139 | Tubular atrophy (HP:0000092) | 2.06530613 |
| 140 | Fair hair (HP:0002286) | 2.06132969 |
| 141 | Renal cortical cysts (HP:0000803) | 2.05855839 |
| 142 | Choroideremia (HP:0001139) | 2.04986170 |
| 143 | Muscle fibrillation (HP:0010546) | 2.04943148 |
| 144 | Adenoma sebaceum (HP:0009720) | 2.04492304 |
| 145 | Angiofibromas (HP:0010615) | 2.04492304 |
| 146 | Abnormality of the musculature of the hand (HP:0001421) | 2.03954401 |
| 147 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.03924781 |
| 148 | Combined immunodeficiency (HP:0005387) | 2.03013607 |
| 149 | Bicornuate uterus (HP:0000813) | 2.00778163 |
| 150 | Dialeptic seizures (HP:0011146) | 1.99284600 |
| 151 | Upper motor neuron abnormality (HP:0002127) | 1.98880700 |
| 152 | Upper limb muscle weakness (HP:0003484) | 1.98256900 |
| 153 | EMG: neuropathic changes (HP:0003445) | 1.97130167 |
| 154 | Achilles tendon contracture (HP:0001771) | 1.96862402 |
| 155 | Postaxial foot polydactyly (HP:0001830) | 1.96547931 |
| 156 | Glossoptosis (HP:0000162) | 1.94377733 |
| 157 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.92691224 |
| 158 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.92510916 |
| 159 | Generalized hypopigmentation of hair (HP:0011358) | 1.90996293 |
| 160 | Resting tremor (HP:0002322) | 1.90113166 |
| 161 | Anencephaly (HP:0002323) | 1.89707238 |
| 162 | Premature graying of hair (HP:0002216) | 1.89537721 |
| 163 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89174092 |
| 164 | Abnormality of alanine metabolism (HP:0010916) | 1.89174092 |
| 165 | Hyperalaninemia (HP:0003348) | 1.89174092 |
| 166 | Prominent occiput (HP:0000269) | 1.88321229 |
| 167 | Meckel diverticulum (HP:0002245) | 1.87577409 |
| 168 | Thyroiditis (HP:0100646) | 1.87455953 |
| 169 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87228829 |
| 170 | Fasciculations (HP:0002380) | 1.87107462 |
| 171 | Hand muscle atrophy (HP:0009130) | 1.86559383 |
| 172 | Amblyopia (HP:0000646) | 1.86447486 |
| 173 | Malnutrition (HP:0004395) | 1.86221475 |
| 174 | Sclerocornea (HP:0000647) | 1.86183630 |
| 175 | Poor coordination (HP:0002370) | 1.85686650 |
| 176 | Photophobia (HP:0000613) | 1.85049034 |
| 177 | Stomatitis (HP:0010280) | 1.84280604 |
| 178 | Type II diabetes mellitus (HP:0005978) | 1.84153762 |
| 179 | Absent speech (HP:0001344) | 1.83224411 |
| 180 | Clumsiness (HP:0002312) | 1.82778646 |
| 181 | Retinitis pigmentosa (HP:0000510) | 1.80598813 |
| 182 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.80121759 |
| 183 | Stomach cancer (HP:0012126) | 1.78804027 |
| 184 | Protruding tongue (HP:0010808) | 1.77894486 |
| 185 | Broad-based gait (HP:0002136) | 1.76778424 |
| 186 | Lissencephaly (HP:0001339) | 1.76093024 |
| 187 | Furrowed tongue (HP:0000221) | 1.75573889 |
| 188 | Polyuria (HP:0000103) | 1.75409955 |
| 189 | Abnormality of dental color (HP:0011073) | 1.74902033 |
| 190 | Autoamputation (HP:0001218) | 1.73979384 |
| 191 | Male pseudohermaphroditism (HP:0000037) | 1.73926072 |
| 192 | Hip dysplasia (HP:0001385) | 1.73418666 |
| 193 | Abnormality of B cell number (HP:0010975) | 1.69681659 |
| 194 | Abnormality of the labia minora (HP:0012880) | 1.69415675 |
| 195 | Short foot (HP:0001773) | 1.69400832 |
| 196 | Astigmatism (HP:0000483) | 1.68821298 |
| 197 | Pigmentary retinal degeneration (HP:0001146) | 1.65142444 |
| 198 | Widely spaced teeth (HP:0000687) | 1.64348209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.57695442 |
| 2 | FRK | 7.41719860 |
| 3 | GRK5 | 5.27438518 |
| 4 | ERN1 | 5.10329387 |
| 5 | GRK6 | 4.69130009 |
| 6 | ADRBK2 | 3.67244985 |
| 7 | TAOK3 | 3.40588893 |
| 8 | GRK1 | 3.19680277 |
| 9 | CSF1R | 3.09946692 |
| 10 | TYRO3 | 2.70257579 |
| 11 | NEK6 | 2.62917629 |
| 12 | MAP4K2 | 2.54934744 |
| 13 | TGFBR2 | 2.52419059 |
| 14 | BMPR1B | 2.46679769 |
| 15 | MATK | 2.45208808 |
| 16 | TTK | 2.43850823 |
| 17 | STK10 | 2.35945116 |
| 18 | MAP3K4 | 2.35528457 |
| 19 | WNK3 | 2.33518709 |
| 20 | MAPK7 | 2.24659105 |
| 21 | ACVR1B | 2.17760094 |
| 22 | TXK | 2.17087834 |
| 23 | GRK7 | 2.12701931 |
| 24 | MOS | 1.88108765 |
| 25 | MAP3K10 | 1.87783055 |
| 26 | MAPK13 | 1.86501052 |
| 27 | PINK1 | 1.84335896 |
| 28 | NUAK1 | 1.81909590 |
| 29 | NTRK1 | 1.74292248 |
| 30 | ZAK | 1.71767831 |
| 31 | WNK1 | 1.67694941 |
| 32 | MAP2K7 | 1.66164409 |
| 33 | CDK7 | 1.64391198 |
| 34 | CSNK1A1L | 1.59792108 |
| 35 | MARK2 | 1.52701152 |
| 36 | PRKG2 | 1.47746907 |
| 37 | INSRR | 1.41336071 |
| 38 | STK39 | 1.40364008 |
| 39 | CAMK4 | 1.33258218 |
| 40 | WNK4 | 1.31266004 |
| 41 | PIK3CG | 1.23837006 |
| 42 | HIPK2 | 1.22557567 |
| 43 | OXSR1 | 1.22492804 |
| 44 | TEC | 1.21918255 |
| 45 | PAK4 | 1.18052491 |
| 46 | MAP3K7 | 1.16922800 |
| 47 | CASK | 1.11455245 |
| 48 | STK38L | 1.10605940 |
| 49 | FGFR3 | 1.09608008 |
| 50 | EPHA2 | 1.09108505 |
| 51 | TRIM28 | 1.03236915 |
| 52 | PRKCE | 1.02563371 |
| 53 | MARK1 | 1.02111106 |
| 54 | DYRK3 | 1.00916624 |
| 55 | AKT2 | 0.98698535 |
| 56 | ALK | 0.98313118 |
| 57 | MKNK2 | 0.97481251 |
| 58 | ADRBK1 | 0.95723250 |
| 59 | PLK2 | 0.94331269 |
| 60 | CHEK2 | 0.94200733 |
| 61 | MAP2K4 | 0.86990509 |
| 62 | DAPK2 | 0.85811497 |
| 63 | CSNK1G2 | 0.83323694 |
| 64 | MAPK12 | 0.82636345 |
| 65 | SIK2 | 0.82397505 |
| 66 | CSK | 0.82222498 |
| 67 | PLK1 | 0.78628149 |
| 68 | SGK2 | 0.77449125 |
| 69 | NTRK3 | 0.77065560 |
| 70 | TNIK | 0.76791835 |
| 71 | TGFBR1 | 0.72952838 |
| 72 | PAK3 | 0.72660493 |
| 73 | MAP2K6 | 0.68897710 |
| 74 | CHEK1 | 0.66595211 |
| 75 | ITK | 0.66016700 |
| 76 | CSNK1G1 | 0.65833786 |
| 77 | PTK2B | 0.64838132 |
| 78 | CSNK1G3 | 0.63257943 |
| 79 | IRAK1 | 0.60714596 |
| 80 | NEK2 | 0.58805203 |
| 81 | MARK3 | 0.56485757 |
| 82 | MUSK | 0.55021991 |
| 83 | NLK | 0.54484698 |
| 84 | CDC7 | 0.54482659 |
| 85 | PLK4 | 0.53849989 |
| 86 | FER | 0.53482092 |
| 87 | EPHA4 | 0.53216912 |
| 88 | PRKCG | 0.53150695 |
| 89 | MTOR | 0.52864231 |
| 90 | PIK3CA | 0.52685319 |
| 91 | PRKAA2 | 0.52386591 |
| 92 | CAMKK2 | 0.51799016 |
| 93 | PKN1 | 0.51048661 |
| 94 | TIE1 | 0.51041288 |
| 95 | CAMK1 | 0.50681805 |
| 96 | AKT3 | 0.50662076 |
| 97 | PRKCH | 0.49826831 |
| 98 | EIF2AK3 | 0.49451501 |
| 99 | SIK1 | 0.48709839 |
| 100 | MAPK4 | 0.48376073 |
| 101 | CAMK1G | 0.48241795 |
| 102 | SRPK1 | 0.47686398 |
| 103 | PRKCQ | 0.47532427 |
| 104 | SGK494 | 0.46192362 |
| 105 | SGK223 | 0.46192362 |
| 106 | FLT3 | 0.45710577 |
| 107 | PDK2 | 0.45178648 |
| 108 | EIF2AK2 | 0.44903697 |
| 109 | DYRK2 | 0.44865477 |
| 110 | PAK1 | 0.44261939 |
| 111 | AURKA | 0.43980856 |
| 112 | RIPK1 | 0.43856261 |
| 113 | CAMK2A | 0.42953069 |
| 114 | LYN | 0.42406944 |
| 115 | CHUK | 0.42035948 |
| 116 | CSNK1D | 0.41719682 |
| 117 | TRIB3 | 0.41014324 |
| 118 | ERBB3 | 0.40867063 |
| 119 | BRD4 | 0.40556908 |
| 120 | ERBB2 | 0.40418518 |
| 121 | CDK4 | 0.40376238 |
| 122 | STK11 | 0.39912673 |
| 123 | RPS6KB2 | 0.39392603 |
| 124 | DYRK1A | 0.39147197 |
| 125 | CDK3 | 0.38980634 |
| 126 | BMX | 0.38962759 |
| 127 | CDK2 | 0.38913723 |
| 128 | PRKCA | 0.38821016 |
| 129 | BCR | 0.38548039 |
| 130 | PRKCZ | 0.37899039 |
| 131 | OBSCN | 0.36753901 |
| 132 | EEF2K | 0.35754626 |
| 133 | PRKACA | 0.35374186 |
| 134 | CDK19 | 0.34603893 |
| 135 | LATS2 | 0.33752462 |
| 136 | IKBKB | 0.33099016 |
| 137 | CDK15 | 0.32721785 |
| 138 | PRKD2 | 0.32203580 |
| 139 | IGF1R | 0.31610048 |
| 140 | PDGFRA | 0.30430507 |
| 141 | MAPKAPK2 | 0.29947200 |
| 142 | CDK11A | 0.28789870 |
| 143 | PRKCI | 0.28332051 |
| 144 | ICK | 0.28219128 |
| 145 | PTK2 | 0.27835320 |
| 146 | CDK18 | 0.27551923 |
| 147 | KIT | 0.26358018 |
| 148 | SYK | 0.25838750 |
| 149 | MAP4K1 | 0.25136420 |
| 150 | PRKCD | 0.24100207 |
| 151 | BLK | 0.23253366 |
| 152 | CSNK1E | 0.21845628 |
| 153 | MAPK10 | 0.21165601 |
| 154 | MAP3K9 | 0.21093130 |
| 155 | CDK14 | 0.20724298 |
| 156 | TNK2 | 0.20600857 |
| 157 | DYRK1B | 0.20149795 |
| 158 | ATM | 0.19865103 |
| 159 | CDK1 | 0.19209123 |
| 160 | MST4 | 0.19203129 |
| 161 | MAPK14 | 0.18836719 |
| 162 | MAPK1 | 0.18667821 |
| 163 | HCK | 0.18594936 |
| 164 | PRKACG | 0.18457691 |
| 165 | MAPKAPK3 | 0.18146546 |
| 166 | INSR | 0.17821025 |
| 167 | PKN2 | 0.17659576 |
| 168 | GSK3B | 0.17193250 |
| 169 | AURKB | 0.16900983 |
| 170 | GSK3A | 0.14526709 |
| 171 | ABL1 | 0.13428049 |
| 172 | RPS6KA2 | 0.12341451 |
| 173 | LCK | 0.11198116 |
| 174 | PRKAA1 | 0.10274041 |
| 175 | BTK | 0.10211273 |
| 176 | IKBKE | 0.10133308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.68483915 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.21839766 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 4.04412784 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.43408765 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.42365363 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.85542513 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.81518127 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.47486269 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.33225658 |
| 10 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.27679561 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20326531 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15947622 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.14375947 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.11477588 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.03425878 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.02882978 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.94477901 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.94174549 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.93835850 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85768662 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.83288592 |
| 22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.79836540 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74221887 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.71106426 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66540332 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66059371 |
| 27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.57439785 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.54819698 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.53876152 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.53705379 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51060837 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.49758692 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44251037 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42417837 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30825671 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.28898131 |
| 37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.28434471 |
| 38 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.28045552 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.24100445 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23380070 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22074984 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.20614614 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20438104 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18798221 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.17536084 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12435430 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09204110 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07934588 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06674856 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.05833739 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04942099 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03864401 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02872585 |
| 54 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01829785 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00984993 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00289124 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99340564 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98809810 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98707147 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98287368 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97934317 |
| 62 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.95903811 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.93873012 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93464849 |
| 65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92415906 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.92010875 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91480337 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89622035 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87697169 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86912945 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86211555 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85394892 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85000036 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84857561 |
| 75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83238181 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82663639 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79734552 |
| 78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.79621021 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79250528 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78862538 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77955594 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77630084 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76672067 |
| 84 | DNA replication_Homo sapiens_hsa03030 | 0.76244596 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76086592 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74666092 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73086093 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70909497 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68594565 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67792552 |
| 91 | Ribosome_Homo sapiens_hsa03010 | 0.67426574 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.66947731 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66736582 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66273628 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65525695 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64650468 |
| 97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64345160 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63905989 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63635960 |
| 100 | Homologous recombination_Homo sapiens_hsa03440 | 0.63621257 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62878715 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62726066 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62195485 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.62078688 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61334143 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60009646 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.58026667 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57857115 |
| 109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57258647 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56790329 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56529908 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54349067 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54059914 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53398917 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53010270 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52649072 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52228060 |
| 118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52010790 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.51579349 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51522823 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.51050594 |
| 122 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50991046 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.50718093 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50035147 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49418997 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48230107 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47649053 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47394826 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.45959444 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.45801356 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44986324 |
| 132 | Mismatch repair_Homo sapiens_hsa03430 | 0.44878049 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44768210 |
| 134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44539214 |
| 135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43525557 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41748520 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41202940 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40336430 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.38204052 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37150944 |
| 141 | Spliceosome_Homo sapiens_hsa03040 | 0.36618859 |
| 142 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36578198 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.35249096 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35182257 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35040853 |
| 146 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34873560 |
| 147 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34394157 |
| 148 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34375643 |
| 149 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33793190 |
| 150 | Base excision repair_Homo sapiens_hsa03410 | 0.33718986 |
| 151 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33117753 |
| 152 | Long-term depression_Homo sapiens_hsa04730 | 0.33099179 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32644216 |
| 154 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32464961 |
| 155 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32246459 |
| 156 | Purine metabolism_Homo sapiens_hsa00230 | 0.32118001 |
| 157 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31708424 |
| 158 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31393602 |
| 159 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31347262 |
| 160 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.31217799 |
| 161 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30443020 |
| 162 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.29916236 |
| 163 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29387387 |
| 164 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28503735 |
| 165 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.25210992 |
| 166 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24709543 |
| 167 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.23168824 |
| 168 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22653590 |

